SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-033117
Filing Date
2023-11-28
Accepted
2023-11-28 17:30:07
Documents
16
Period of Report
2023-11-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tmbr20231128_8k.htm   iXBRL 8-K 36835
2 EXHIBIT 99.1 NOL ORDER ex_600686.htm EX-99.1 174644
3 EXHIBIT 99.2 PRESS RELEASE, DATED NOVEMBER 28, 2023 ex_600687.htm EX-99.2 16337
8 jks01.jpg GRAPHIC 2463
  Complete submission text file 0001437749-23-033117.txt   395431

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmbr-20231121.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmbr-20231121_def.xml EX-101.DEF 11425
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmbr-20231121_lab.xml EX-101.LAB 15311
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmbr-20231121_pre.xml EX-101.PRE 11585
10 EXTRACTED XBRL INSTANCE DOCUMENT tmbr20231128_8k_htm.xml XML 2562
Mailing Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059
Business Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059 (917) 697-3130
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 231447687
SIC: 2834 Pharmaceutical Preparations